“Some element of the earnings compression has been priced in. Probably not all of the risk there, but that’s probably not crazy,” said Matt Benkendorf, chief investment officer at Vontobel Quality Growth Boutique. “The market gets quite scrambled when it has to digest a few exogenous things at once.”
from Economic Times https://ift.tt/QGwMBYh
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivi...
No comments:
Post a Comment